Trevi Therapeutics, Inc. (TRVI) Return On Assets % [USD] 2019 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Trevi Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2019 to 2024.
  • Trevi Therapeutics, Inc. Return On Assets for the quarter ending March 31, 2024 was -36.8 %, a 46.4% decline year-over-year.
  • Trevi Therapeutics, Inc. annual Return On Assets for 2023 was -28.9 %, a 10% increase from 2022.
  • Trevi Therapeutics, Inc. annual Return On Assets for 2022 was -32.1 %, a 64% increase from 2021.
  • Trevi Therapeutics, Inc. annual Return On Assets for 2021 was -89.3 %, a 39.2% decline from 2020.
Return On Assets, Quarterly (% [USD])
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -36.8 -11.7 -46.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -28.9 +3.22 +10% Oct 1, 2023 Dec 31, 2023
Q3 2023 -24.5 +21.6 +46.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -23.3 +45.2 +66% Apr 1, 2023 Jun 30, 2023
Q1 2023 -25.1 +69.1 +73.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -32.1 +57.2 +64% Oct 1, 2022 Dec 31, 2022
Q3 2022 -46.2 +40.8 +46.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -68.5 +7.29 +9.62% Apr 1, 2022 Jun 30, 2022
Q1 2022 -94.3 -26.5 -39.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -89.3 -25.1 -39.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -87 -32.1 -58.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -75.8 -23.4 -44.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -67.7 -21.2 -45.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -64.2 -16.4 -34.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -54.9 +5.55 +9.19% Jul 1, 2020 Sep 30, 2020
Q2 2020 -52.4 Apr 1, 2020 Jun 30, 2020
Q1 2020 -46.6 Jan 1, 2020 Mar 31, 2020
Q4 2019 -47.7 Oct 1, 2019 Dec 31, 2019
Q3 2019 -60.4 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.